share_log

Arbutus Biopharma | 8-K: Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

SEC announcement ·  Feb 29 07:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more